Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
The Korean Journal of Parasitology|June 16, 2007
Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in ThailandSrivicha Krudsood, Noppadon Tangpukdee, Sant Muangnoicharoen, et al.
Molecules (Basel, Switzerland)|September 9, 2023
Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A ReviewIram Iqbal, Polrat Wilairatana, Fatima Saqib, et al.
Molecules (Basel, Switzerland)|April 12, 2022
Vegetables and Their Bioactive Compounds as Anti-Aging DrugsHamza Mechchate, Aicha El Allam, Nasreddine El Omari, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|July 11, 2008
Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malariaSrivicha Krudsood, Noppadon Tangpukdee, Vipa Thanchatwet, et al.
Scientific Reports|November 12, 2021
C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysisPolrat Wilairatana, Praphassorn Mahannop, Thanita Tussato, et al.
Molecules (Basel, Switzerland)|May 28, 2022
Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative DiseasesAbdur Rauf, Himani Badoni, Tareq Abu-Izneid, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 14, 2006
A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malariaOranan Prommano, Urai Chaisri, Gareth D H Turner, et al.
Molecules (Basel, Switzerland)|March 16, 2026
RETRACTED: Rauf et al. Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases. Molecules 2022, 27, 3194Abdur Rauf, Himani Badoni, Tareq Abu-Izneid, et al.
Molecules (Basel, Switzerland)|May 13, 2023
Anticancer Potentials of the Lignan Magnolin: A Systematic ReviewMd Shimul Bhuia, Polrat Wilairatana, Raihan Chowdhury, et al.
The Korean Journal of Parasitology|September 14, 2006
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in ThailandSrivicha Krudsood, Polrat Wilairatana, Noppadon Tangpukdee, et al.
Pageof 24